Moreover, a recent study suggests that COL10A1 expression may be regulated by non-steroidal anti-inflammatory drugs [42], which have protective effect on CRC risk, suggesting that the mechanism of COL10A1 overexpression might be also related to inflammatory processes. Here, COL10A1 is linked to colorectal carcinoma.